google-site-verification: googlec7193c3de77668c9.html

Scientists develop first-of-its-kind antibody to block Epstein Barr virus

[
Fred Hutch Cancer Center scientists reached a crucial milestone in blocking Epstein Barr virus (EBV), a pathogen estimated to infect 95% of the global population that is linked to multiple types of cancer, neurodegenerative diseases and other chronic health conditions. Using mice with human antibody genes, the research team developed new genetically human monoclonal antibodies that prevent two key antigens on the surface of the virus from binding to and entering human immune cells.


Source link

Advertisements
Views: 2

See also  Adding a lower cutoff value for CA19-9 may identify additional high-risk cases of pancreatic cancer

Check Also

What do Sardinia's Blue Zone elders do differently that helps them age so well physically and mentally?

[ People are living longer than they did at the turn of the 20th century, …

Do breast cancer and irregular heartbeat have common risk factors and rates?

[ Alcohol use and smoking are linked to breast cancer and atrial fibrillation/flutter in women …

Dry mRNA vaccine patches reveal design rules for room-temperature storage

[ New research could help make future mRNA vaccines easier to store and distribute. The …

Leave a Reply

Available for Amazon Prime
tech news today.